Abstract:Purpose: To evaluate characteristics of obstructions of the hepatic veins (HVs) in Chinese patients, technical aspects of puncture of the HVs, short- and mid-term outcomes, and complications of endovascular treatment.Patients and Methods: Forty-eight HV patients with different degrees of symptoms and signs of portal hypertension were enrolled in our study. Endovascular treatments with balloon and stents were performed. Catheter-directed thrombolysis (CDT) was performed in patients with thrombosis in the HVs. For patients with lesions of both the HVs and the inferior vena cava (IVC), balloon expansions or stenting were performed at the IVC lesions also.Results: Endovascular treatments were successful in 43 patients. The technically success rate was 89.6% (43/48). Fifteen patients underwent solely balloon expansions, 28 patients had balloon expansions and stentings, 5 patients underwent CDT, and 3 patients had implanted stents in the IVC lesions at the same time. The symptoms of portal hypertension were alleviated in 39 patients postoperatively. In the other 4 cases portal hypertension was mildly alleviated at discharge. Thirty-nine of the 43 patients were followed up for an average of 24 +/- 1.3 months (range, 6-62 months). Ascites were completely resolved in 32 cases, with a small amount of ascites in 4 patients and moderate to massive amounts in 3 patients. Hepatomegaly and splenomegaly completely disappeared in 30 patients and still could be touched in 6 patients. The HVs were patent in 29 patients. Restenosis and re-occlusion of the HVs appeared in 4 cases. All patients were successfully treated by endovascular treatments.Conclusions: Endovascular treatments for patients with obstruction of the HVs have a high technical success rate, fewer complications, and better short- and mid-term clinical outcome. The key to successful endovascular treatment is successful puncture of HVs. For patients who have occlusive lesions of HVs combined with occlusive IVC, recanalization of the lesions of the HVs could achieve good results.

Good Clinical Outcomes in Budd–Chiari Syndrome with Hepatic Vein Occlusion

Staged Management of Budd-Chiari Syndrome Caused by Co-Obstruction of the Inferior Vena Cava and Main Hepatic Veins.

Endovascular treatment of Budd-Chiari syndrome with occlusion of hepatic veins

Discrimination between Budd-Chiari Syndrome,Hepatic Veno Occlusive Disease and Liver Cirrhosis

Advanced Imaging Techniques Used in Direct Portosystemic Shunt Creation in Budd-Chiari Syndrome with Complex Venous Anatomy

S4263 Budd-Chiari Plus a Friend - A Case of Chronic Budd Chiari Syndrome and Simultaneous Superior Mesenteric Vein Thrombus

Identification of Budd - Chiari Syndrome, Hepatic Sinusoidal Obstruction Syndrome and Hepatic Cirrhosis

Acute Iatrogenic Budd-Chiari Syndrome Following Hepatectomy for Hepatolithiasis: A Report of Two Cases

Modified Transjugular Intrahepatic Portosystemic Shunt In The Treatment Of Budd-Chiari Syndrome

Analysis of Surgical Treatment Results in 120 Cases of Budd-Chiari Syndrome

Point-of-care ultrasound in the diagnosis and treatment of Budd-Chiari syndrome: A rare case report and literature review

Liver cirrhosis caused by chronic Budd–Chiari syndrome

Clinical profile and outcomes of hepatocellular carcinoma in primary Budd-Chiari syndrome

Significance of accessory hepatic vein pressure reduction in treatment of Budd-Chiari syndrome

The Clinical Characteristics of 151 Cases of Budd-Chiari Syndrome

Rapidly progressing Budd-Chiari syndrome complicated by hepatocellular carcinoma

Radical Surgery under Genuine Direct Vision for the Treatment of Budd-Chiari Syndrome.

Interventions in Budd-Chiari syndrome: an updated review

Endovascular Treatment Of Budd-Chiari Syndrome With Hepatic Vein Obstruction In China

Modified transjugular intrahepatic portosystemic shunt in the treatment of Budd‐Chiari syndrome

Budd-Chiari syndrome and its associated hepatocellular carcinoma: Clinical risk factors and potential immunotherapeutic benefit analysis